ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ABOS Acumen Pharmaceuticals Inc

3.25
0.00 (0.00%)
Pre Market
Last Updated: 04:05:56
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Acumen Pharmaceuticals Inc ABOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 3.25 04:05:56
Open Price Low Price High Price Close Price Prev Close
3.25
more quote information »

Recent News

Date Time Source Heading
5/14/202416:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202407:35EDGAR2Form 8-K - Current report
5/14/202407:00GLOBEAcumen Pharmaceuticals Reports First Quarter 2024 Financial..
5/13/202416:00GLOBEAcumen Pharmaceuticals to Participate in the H.C. Wainwright..
5/08/202417:47GLOBEAcumen Pharmaceuticals to Participate in the 2024 Bank of..
5/08/202408:00GLOBEAcumen Pharmaceuticals Announces First Patient Dosed in..
5/07/202416:00GLOBEAcumen Pharmaceuticals to Report First Quarter Results on..
4/16/202408:00GLOBEAcumen Pharmaceuticals Presents First Comprehensive Clinical..
4/04/202408:00GLOBEAcumen Pharmaceuticals Collaborates with Lonza to Advance..
3/26/202407:00GLOBEAcumen Pharmaceuticals Reports Financial Results for the..
3/21/202408:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights, Including..
3/19/202416:00GLOBEAcumen Pharmaceuticals to Report Fourth Quarter and Year-End..
3/12/202416:00GLOBEAcumen Pharmaceuticals to Participate in the Stifel 2024 CNS..
3/08/202408:50GLOBEAcumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid..
2/21/202408:00GLOBEAcumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid..
2/14/202408:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202417:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/01/202407:16EDGAR2Form 8-K - Current report
2/01/202407:00GLOBEAcumen Pharmaceuticals Appoints Dr. James Doherty as..
1/19/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202416:36EDGAR2Form 144 - Report of proposed sale of securities
1/19/202416:35EDGAR2Form 144 - Report of proposed sale of securities
1/18/202416:29EDGAR2Form 144 - Report of proposed sale of securities
1/18/202416:28EDGAR2Form 144 - Report of proposed sale of securities
1/18/202416:27EDGAR2Form 144 - Report of proposed sale of securities
1/12/202408:42EDGAR2Form 8-K - Current report
1/08/202408:33EDGAR2Form 8-K - Current report
1/04/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:15GLOBEAcumen Pharmaceuticals to Present at the 42nd Annual J.P...
12/04/202307:45EDGAR2Form 8-K - Current report
11/13/202317:10EDGAR2Form 8-K - Current report
11/13/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202307:20EDGAR2Form 8-K - Current report
11/13/202307:00GLOBEAcumen Pharmaceuticals Secures $50.0 Million Credit Facility..
11/07/202316:01GLOBEAcumen Pharmaceuticals to Participate in the Stifel..
11/06/202316:01GLOBEAcumen Pharmaceuticals to Report Third Quarter Financial..
11/06/202307:30GLOBEAcumen Pharmaceuticals, Inc. and Halozyme Enter Global..
11/02/202316:00GLOBEAcumen Pharmaceuticals to Participate in the UBS Biopharma..
10/27/202309:25GLOBEAcumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates..
10/04/202308:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights from..
9/19/202316:00GLOBEAcumen Pharmaceuticals to Participate in the Cantor Global..

Your Recent History

Delayed Upgrade Clock